Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Journal of the American College of Cardiology|April 1, 1992
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-IIH L Greene, D M Roden, R J Katz, et al.
Circulation Research|February 11, 1991
Virtual cathode effects during stimulation of cardiac muscle. Two-dimensional in vivo experimentsJ P Wikswo, T A Wisialowski, W A Altemeier, et al.
Circulation|October 23, 1997
Normalization of acquired QT prolongation in humans by intravenous potassiumA M Choy, C C Lang, D M Chomsky, et al.
Pacing and Clinical Electrophysiology : PACE|September 1, 1991
Intravenous 3-methoxy-O-desmethyl-encainide in reentrant supraventricular tachycardia: a randomized double-blind placebo-controlled trial in patients undergoing EP studyD L Ware, J T Lee, K T Murray, et al.
The Journal of Clinical Investigation|February 7, 1998
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitorsR B Kim, M F Fromm, C Wandel, et al.
Clinical Pharmacology and Therapeutics|May 1, 1991
Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibersJ Turgeon, C Funck-Brentano, H T Gray, et al.
American Heart Journal|July 1, 1980
Tocainide therapy for refractory ventricular arrhythmiasD M Roden, D M Roden, S B Reele, et al.
American Heart Journal|October 20, 1998
Abnormalities of the QT interval in primary disorders of autonomic failureA M Choy, C C Lang, D M Roden, et al.
Clinical Pharmacology and Therapeutics|January 3, 2013
Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVUT L McGregor, S L Van Driest, K B Brothers, et al.
Circulation|May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomersH K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Journal of the American College of Cardiology|April 1, 1992
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-IIH L Greene, D M Roden, R J Katz, et al.
Circulation Research|February 11, 1991
Virtual cathode effects during stimulation of cardiac muscle. Two-dimensional in vivo experimentsJ P Wikswo, T A Wisialowski, W A Altemeier, et al.
Circulation|October 23, 1997
Normalization of acquired QT prolongation in humans by intravenous potassiumA M Choy, C C Lang, D M Chomsky, et al.
Pacing and Clinical Electrophysiology : PACE|September 1, 1991
Intravenous 3-methoxy-O-desmethyl-encainide in reentrant supraventricular tachycardia: a randomized double-blind placebo-controlled trial in patients undergoing EP studyD L Ware, J T Lee, K T Murray, et al.
The Journal of Clinical Investigation|February 7, 1998
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitorsR B Kim, M F Fromm, C Wandel, et al.
Clinical Pharmacology and Therapeutics|May 1, 1991
Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibersJ Turgeon, C Funck-Brentano, H T Gray, et al.
American Heart Journal|July 1, 1980
Tocainide therapy for refractory ventricular arrhythmiasD M Roden, D M Roden, S B Reele, et al.
American Heart Journal|October 20, 1998
Abnormalities of the QT interval in primary disorders of autonomic failureA M Choy, C C Lang, D M Roden, et al.
Clinical Pharmacology and Therapeutics|January 3, 2013
Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVUT L McGregor, S L Van Driest, K B Brothers, et al.
Circulation|May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomersH K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Pageof 24